自动体外心臟去颤器市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品类型、最终用户、地区、竞争细分

2022 年全球自动体外心臟去颤器市场价值为32.152 亿美元，预计在预测期内将呈现强劲成长，到2028 年复合年增长率为7.0%。除颤器作为医疗设备，用于对患者进行电击或脉衝治疗。心臟以恢復正常的心跳。它们用于预防或治疗异常、缓慢或快速的心律，称为心律不整。此外，除颤器可以使突然停止跳动的心臟恢復活力。除颤器存在多种设计和操作方法。自动体外心臟去颤器 (AED) 在公共场所随处可见，未经训练的个人也可以在紧急情况下使用，从而有可能挽救心臟骤停的患者。其他类型的除颤器，例如可穿戴式心律转復除颤器 (WCD) 和植入式心律转復除颤器 (ICD)，可用于预防危及生命的心律不整高风险个体的猝死。适应在家中使用除颤器可能需要时间和精力，因此意识到潜在问题至关重要。

主要市场驱动因素：

心血管疾病的发生率不断上升

市场概况
预测期	2018-2028
2022 年市场规模	150001万美元
2028 年市场规模	225485万美元
2023-2028 年复合年增长率	7.04%
成长最快的细分市场	全自动体外心臟去颤器
最大的市场	北美洲

儘管紧急心臟护理的进步提高了患者的生存机会，但心血管疾病的流行仍然是全球死亡的重要原因。研究表明，每年约有 35 万名美国人死于心臟病，其中一半是在医疗机构之外因心臟停止功能而意外死亡的。突发性心臟骤停是这些早死的原因之一。心室颤动是一种心律不整疾病，通常会引发心臟骤停。自动体外心臟去颤器 (AED) 因其能够透过电击治疗异常心律而越来越受欢迎。这些设备旨在检测和治疗两种特定类型的心律不整：无脉性室性心动过速和心室颤动。未来几年，随着越来越多地使用这些设备来治疗心臟骤停的患者，全球 AED 市场预计将带来创收机会。此外，越来越多的人依赖吸烟和饮酒可能有助于繁荣的市场前景。

先进除颤器设备的采用率增加

先进除颤器设备的采用显着增加。这些现代设备配备了用户友好的介面和自动化功能，使更广泛的医疗保健专业人员（包括非专家）可以使用它们。这种可访问性在紧急情况下非常有用，可以自信地操作这些设备，改善患者护理和治疗结果。随着已开发国家和发展中国家的医疗支出持续成长，用于升级医疗设备和技术的投资不断增加。为此，医院和医疗机构正在优先考虑使用先进的除颤器，以满足老年患者的独特需求并提供最佳护理。

对优质医疗服务的需求也不断上升。及时的医疗干预至关重要，尤其是在心臟骤停等危急情况下。除颤器在快速应对危及生命的心律不整方面发挥着至关重要的作用，可显着提高成功復苏的机会和更好的患者预后。透过优质照护协议优先考虑医疗机构、公共场所甚至家庭中除颤器的可用性和正确使用，从而提高生存率。透过迅速恢復正常心律，除颤器有助于改善患者预后并减少长期健康后果。对优质护理的关注不仅提高了患者的体验和满意度，而且还推动了对先进除颤器技术的投资。

主要市场趋势

下一代除颤器的进步

由于下一代除颤器的进步，除颤器市场预计将加速成长，超出最初的预期。除颤器在识别和解决设备相关问题方面发挥着至关重要的作用。心臟骤停 (SCA) 是全球死亡的主要原因，具有潜在的死亡风险。然而，早期介入和除颤可以有效地控制这种情况。在体外去颤器中，自动体外心臟去颤器 (AED) 占据市场主导地位，并且由于越来越多的心臟衰竭患者依赖它们，预计将出现显着扩张。不断增长的需求与更广泛的 AED 的可用性一致。目前，穿戴式装置比手动体外心臟去颤器具有竞争优势。此外，预计未来几年市场成长将受到皮下植入式心臟復律去颤器(S-ICD)、MRI 相容植入式心臟復律去颤器(ICD) 和心臟再同步治疗去颤器(CRT -D) 的推动。

市场参与者投资增加

随着技术的进步和对自动体外心臟去颤器的需求不断增长，市场参与者不断增加在该领域的投资，推动未来几年所分析市场的预期成长。微创心律管理有限公司是微创科学公司的子公司，专注于植入式心律调节器和除颤器设备的开发和商业化，以及管理心律不整的相关创新，于2021 年7 月就其1.5亿美元C 轮融资签署了最终协议。市场参与者不断增加的投资和合作是市场扩张的动力。

自动体外颤动市场的主要参与者正在加大研发投资，以促进新产品的创造。根据飞利浦2020年年报，该公司2018年的研发费用为17.59亿欧元，2019年为18.84亿欧元，2020年为19.15亿欧元。这种不断增加的投资推动了市场的扩张。

细分市场洞察

产品类型见解：

从产品类型来看，全球除颤器市场分为手动体外心臟去颤器、全自动体外心臟去颤器（AED）、穿戴式心臟復律去颤器。到 2022 年，AED 细分市场将占据重要的市场份额。AED 是便携式设备，旨在帮助心臟骤停的个人。自动体外心臟去颤器是一种能够分析心律并提供电击或去颤以恢復有效心律的医疗设备。

最终使用者见解

最终用户部分分为医院、院前、公共访问市场、替代护理市场和家庭。由于心臟病患者在医院接受治疗的频率较高以及医疗机构进行的手术普遍存在，因此预计医院部门将在市场上占据主导地位。医院更频繁地使用 ICD 和体外除颤器来治疗心臟骤停的患者以及用于其他医疗目的。截至 2021 年 1 月，波士顿科学公司报告称，全球已销售约 659,000 个 ICD。与 2020 年 1 月分发的 60 万份 ICD 相比，大幅增加了 5.9 万份，显示市场需求强劲。

区域见解：

北美地区在 2022 年的收入份额最高，成为最大的贡献者。关键参与者的大量存在、提高公众使用 AED 可用性的支持性法规以及医疗机构中外部除颤器的广泛采用促成了这种主导地位。值得注意的是，美国心臟协会 (AHA) 等受人尊敬的组织主张实施全面的公共除颤 (PAD) 计划。这些计划强调 AED 的策略部署、定期维护和测试、急救人员培训、EMS 协调和持续品质改进。

相较之下，预计未来几年欧洲体外心臟去颤器市场将出现最快的成长。这可以归因于完善的医疗基础设施、大量易患心血管事件的老年人口以及关键行业参与者的存在。一个典型的例子是 WEINMANN Emergency Medical Technology GmbH + Co. KG，这是一家德国製造商，以其专为復苏和患者监护而设计的 MEDUCORE Standard 系列体外除颤器而闻名。这些设备供紧急医疗服务人员、军事医疗团队和医院使用。

主要市场参与者

• 皇家飞利浦公司
• 史赛克
• 佐尔医疗公司
• 日本光电株式会社
• 普罗杰蒂公司
• 席勒公司
• MS 威斯特伐利亚有限公司
• 贝克森有氧运动
• 银线医疗科技列兵。有限公司
• 梅迪纳有限公司

可用的客製化：

全球自动体外心臟去颤器市场报告以及给定的市场资料，技术科学研究根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项：

公司资讯

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球自动体外心臟去颤器市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型（手动体外心臟去颤器、全自动体外去颤器、穿戴式心臟復律去颤器）
  • 按最终用户（医院、院前急救、公共服务市场、替代护理市场、家庭）
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：北美自动体外心臟去颤器市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲自动体外心臟去颤器市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区自动体外心臟去颤器市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲自动体外心臟去颤器市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲自动体外心臟去颤器市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非自动体外心臟去颤器
  • 沙乌地阿拉伯自动体外心臟去颤器
  • 阿联酋自动体外心臟去颤器

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 产品发布
• 併购
• 最近的发展

第 13 章：全球自动体外心臟去颤器市场：SWOT 分析

第14章：竞争格局

• 商业概览
• 应用程式产品
• 最近的发展
• 主要人员
• SWOT分析
  • Koninklijke Philips NV
  • Stryker
  • Zoll Medical Corporation
  • Nihon Kohden Corporation
  • ProgettiSrl
  • Schiller AG
  • MS Westfalia GmbH
  • Bexen Cardio
  • Silverline Meditech Pvt. Ltd.
  • Mediana Co., Ltd.

第 15 章：策略建议

第 16 章：关于我们与免责声明

The Global Automated External Defibrillator Market was valued at USD 3,215.2 million in 2022 and is expected to exhibit robust growth in the forecast period, with a CAGR of 7.0% through 2028. Defibrillators, as medical devices, are utilized to administer electric shocks or pulses to the heart in order to restore a regular heartbeat. They are employed to prevent or treat abnormal, slow, or fast heart rhythms known as arrhythmias. Additionally, defibrillators can revive a heart that has suddenly ceased beating. Various designs and operational methods exist for defibrillators. Automated external defibrillators (AEDs) are widely accessible in public places and can be utilized by untrained individuals in emergency situations, potentially saving someone experiencing cardiac arrest. Other types of defibrillators, such as wearable cardioverter defibrillators (WCDs) and implanted cardioverter defibrillators (ICDs), are employed to prevent sudden death in individuals at high risk of life-threatening arrhythmias. Adjusting to having a defibrillator at home may require time and effort, making awareness of potential issues crucial.

Key Market Drivers:

Growing Incidence of Cardiovascular Diseases

Market Overview
Forecast Period	2018-2028
Market Size 2022	USD 1500.01 Million
Market Size 2028	USD 2254.85 Million
CAGR 2023-2028	7.04%
Fastest Growing Segment	Fully Automated External Defibrillator
Largest Market	North America

The prevalence of cardiovascular diseases remains a significant cause of mortality globally, despite advancements in emergency cardiac care that enhance a patient's chances of survival. Research indicates that approximately 350,000 Americans succumb to heart disease annually, with half of these fatalities occurring unexpectedly outside of medical facilities when the heart ceases to function. Sudden cardiac arrest, characterized by its abrupt onset, accounts for the majority of these untimely deaths. Ventricular fibrillation, an irregular heart rhythm disorder, is typically responsible for triggering sudden cardiac arrest. The automated external defibrillator (AED) is gaining popularity due to its ability to administer electric shocks for treating abnormal heart rhythms. These devices are designed to detect and treat two specific types of cardiac arrhythmias: pulseless ventricular tachycardia and ventricular fibrillation. In the coming years, the global market for AEDs is expected to present revenue-generating opportunities, driven by the increasing use of these devices in treating patients experiencing sudden cardiac arrest. Furthermore, the growing number of individuals dependent on smoking and alcohol consumption could contribute to prosperous market prospects.

Increase in Adoption of Advanced Defibrillator Devices

The adoption of advanced defibrillator devices has seen a significant increase. These modern devices are equipped with user-friendly interfaces and automated features, making them accessible to a wider range of healthcare professionals, including non-specialists. This accessibility has been instrumental in emergency situations, where these devices are confidently operated, improving patient care and outcomes. As healthcare spending continues to rise, both in developed and developing countries, there is a growing investment in upgrading medical equipment and technologies. In line with this, hospitals and healthcare facilities are prioritizing the implementation of advanced defibrillators to meet the unique needs of older patients and provide optimal care.

The demand for quality medical care has also been on the rise. Timely medical interventions are crucial, especially in critical situations like cardiac arrest. Defibrillators play a vital role in rapid response to life-threatening arrhythmias, significantly improving the chances of successful resuscitation and better patient outcomes. The availability and proper use of defibrillators in healthcare facilities, public spaces, and even homes are prioritized through quality care protocols, leading to higher survival rates. By promptly restoring normal heart rhythms, defibrillators contribute to better patient outcomes and reduced long-term health consequences. This focus on quality care not only enhances patient experience and satisfaction but also drives investments in advanced defibrillator technologies.

Technological advancements in healthcare have paved the way for the development of comprehensive end-to-end solutions in the defibrillator market. Favorable government initiatives, coupled with high healthcare expenditures, have created an environment conducive to innovation. Market participants are actively engaged in integrating innovative hardware and sophisticated software, expanding the scope of pre-hospital care for first responders. Notably, companies like Royal Philips have introduced remote monitoring and defibrillator solutions that enable real-time data transfer, revolutionizing pre-hospital care. Startups also play a significant role in driving market growth through their contributions to the defibrillator industry.

However, the market still faces challenges, including accessibility issues with external defibrillators. Studies have shown that the likelihood of an automated external defibrillator (AED) being nearby during a cardiac arrest is low, and there may be further restrictions on access due to closed buildings. Out-of-hospital cardiac arrest remains a significant cause of fatalities, with low survival rates. The limited use of AEDs in public settings can be attributed to concerns about legal liability, training requirements, limited access, and lack of general awareness. Nonetheless, research has unequivocally demonstrated that immediate access to an AED significantly enhances survival chances.

Strict rules and regulations also pose challenges to the defibrillator market. However, with ongoing advancements and initiatives, the industry continues to progress, aiming to overcome these obstacles and improve healthcare outcomes for patients.

Regulatory authorities established by governments worldwide enforce rigorous regulations and policies to govern the automated external defibrillators market. These measures ensure the accessibility of safe, appropriate, and affordable devices that serve their medical purpose for the public. However, these regulations can present challenges for vendors, resulting in delayed approvals and occasional product recalls that incur significant costs.

The licensing, evaluation, surveillance, and control of medical devices have become increasingly intricate for national regulatory authorities. The growing number of new products, quality concerns, and technical issues arising from rapid scientific advancements pose significant hurdles. Consequently, governments are implementing even more stringent regulations, further impacting market growth.

Key Market Trends

Advancements in Next-Generation Defibrillators

The defibrillator market is projected to experience accelerated growth, surpassing initial expectations, owing to advancements in next-generation defibrillators. Defibrillators play a crucial role in identifying and resolving device-related issues. Sudden Cardiac Arrest (SCA), a leading cause of global mortality, carries potential fatality. However, early intervention and defibrillation can effectively manage this condition. Among external defibrillators, Automated External Defibrillators (AEDs) dominate the market and are expected to witness significant expansion, driven by the increasing number of heart failure patients relying on them. The growing demand aligns with the availability of a wider range of AEDs. Currently, wearables hold a competitive edge over manual external defibrillators. Furthermore, market growth is anticipated to receive a boost from Subcutaneous Implantable Cardioverter-Defibrillators (S-ICDs), MRI-compatible Implantable Cardioverter-Defibrillators (ICDs), and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) in the upcoming years.

Increase in Investments by Market Players

With the advancement of technology and the growing demand for automated external defibrillators, market participants are consistently increasing their investment in the field, propelling the projected growth of the analyzed market in the coming years. MicroPort Cardiac Rhythm Management Limited, a subsidiary of MicroPort Scientific Corporation focused on the development and commercialization of implantable pacemaker and defibrillator equipment, along with associated innovations to manage cardiac rhythm disorders, entered into definitive agreements in July 2021 regarding its USD 150 million Series C financing. Such escalating investment and collaborations by market participants serve as drivers for the expansion of the market.

The key players in the automatic external fibrillation market are intensifying their investment in research and development to foster the creation of new products. According to Philips' annual report for 2020, the company incurred research and development expenses amounting to EUR 1,759 million in 2018, EUR 1,884 million in 2019, and EUR 1,915 million in 2020. This increasing investment fuels the expansion of the market.

Segmental Insights

Product Type Insights:

In terms of product type, the global defibrillator market is categorized into Manual External Defibrillator, Fully Automated External Defibrillator (AED), Wearable Cardioverter Defibrillator. The AED segment holds a significant market share in 2022. AEDs are portable devices designed to assist individuals in sudden cardiac arrest. An automated external defibrillator is a medical device capable of analyzing the heart's rhythm and delivering an electrical shock or defibrillation to restore an effective rhythm to the heart.

End User Insights

The end user segment is categorized into Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, and Home. The Hospitals segment is projected to have a dominant presence in the market due to the higher frequency of cardiac patients receiving care in hospitals and the prevalence of procedures carried out in healthcare facilities. Hospitals employ ICDs and external defibrillators more frequently for the treatment of patients who have experienced sudden cardiac arrest and for other medical purposes. As of January 2021, Boston Scientific reported a worldwide distribution of approximately 659,000 ICDs. This represents a significant increase of 59,000 compared to the 600,000 ICDs distributed by January 2020, indicating a strong demand in the market.

Regional Insights:

North America accounted for the highest revenue share in 2022, making it the largest contributor. The significant presence of key players, supportive regulations to enhance the availability of public access AEDs, and the widespread adoption of external defibrillators in healthcare facilities contribute to this dominance. Notably, esteemed organizations like the American Heart Association (AHA) in the U.S. advocate for the implementation of comprehensive Public Access Defibrillation (PAD) programs. These programs emphasize strategic placement of AEDs, regular maintenance and testing, responder training, EMS coordination, and continuous quality improvement.

In contrast, Europe is projected to experience the fastest growth in the external defibrillators market in the coming years. This can be attributed to the well-established healthcare infrastructure, a sizable geriatric population susceptible to cardiovascular events, and the presence of key industry players. A prime example is WEINMANN Emergency Medical Technology GmbH + Co. KG, a German manufacturer renowned for its MEDUCORE Standard series of external defibrillators designed for resuscitation and patient monitoring. These devices are intended for use by emergency medical services personnel, military medical corps, and hospitals.

Key Market Players

• Koninklijke Philips N.V.
• Stryker
• Zoll Medical Corporation
• Nihon Kohden Corporation
• ProgettiSrl
• Schiller AG
• MS Westfalia GmbH
• Bexen Cardio
• Silverline Meditech Pvt. Ltd.
• Mediana Co., Ltd.

Report Scope:

In this report, the Global Automated External Defibrillator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated External Defibrillator Market, By Product Type:

• Manual External Defibrillator
• Fully Automated External Defibrillator
• Wearable Cardioverter Defibrillator

Automated External Defibrillator Market, By End User:

• Hospitals
• Pre-Hospitals
• Public Access Market
• Alternate Care Market
• Home

Automated External Defibrillator Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated External Defibrillator Market.

Available Customizations:

Global Automated External Defibrillator Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Automated External Defibrillator Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Manual External Defibrillator, Fully Automated External Defibrillator, Wearable Cardioverter Defibrillator)
  • 5.2.2. By End User (Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, Home)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Market Map

6. North America Automated External Defibrillator Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Automated External Defibrillator Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Automated External Defibrillator Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Automated External Defibrillator Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End User

7. Europe Automated External Defibrillator Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Automated External Defibrillator Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Automated External Defibrillator Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Automated External Defibrillator Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End User
  • 7.3.4. France Automated External Defibrillator Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Automated External Defibrillator Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Automated External Defibrillator Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Automated External Defibrillator Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Automated External Defibrillator Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Automated External Defibrillator Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Automated External Defibrillator Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Automated External Defibrillator Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By End User

9. South America Automated External Defibrillator Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Automated External Defibrillator Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Automated External Defibrillator Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Automated External Defibrillator Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Automated External Defibrillator Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Automated External Defibrillator Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Automated External Defibrillator Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Automated External Defibrillator Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Product Launches
• 12.2. Mergers & Acquisitions
• 12.3. Recent Developments

13. Global Automated External Defibrillator Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Application Offerings
• 14.3. Recent Developments
• 14.4. Key Personnel
• 14.5. SWOT Analysis
  • 14.5.1. Koninklijke Philips N.V.
  • 14.5.2. Stryker
  • 14.5.3. Zoll Medical Corporation
  • 14.5.4. Nihon Kohden Corporation
  • 14.5.5. ProgettiSrl
  • 14.5.6. Schiller AG
  • 14.5.7. MS Westfalia GmbH
  • 14.5.8. Bexen Cardio
  • 14.5.9. Silverline Meditech Pvt. Ltd.
  • 14.5.10. Mediana Co., Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer